The EDC is live today — see what ships now
All studies
NCT06851988From ClinicalTrials.govRecruiting

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

  • Aging
  • High-intensity Interval Training
  • Head and Neck Cancers - Tonsils

At a glance

Phase
Phase not stated
Study type
Interventional
Sponsor
Chang Gung Memorial Hospital
Enrolment target
290
Started
3 May 2023
Main results due
30 October 2026
Study sites
1
Registry updated
24 September 2026

Can you take part?

  • Ages 20 years to 80 years.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

1. Age ≥20
2. Pathology:Squamous cell carcinoma
3. Need CCRT treatment
4. ECOG PS\<2
5. Agree with blood drawing, excise training, questionnaire

Exclusion Criteria:

1. ECOG PS≥2
2. Unable to tolerate basic exercise, or CCRT treatment
3. Mental illness or any medical illness or concurrent illness that may be aggravated by exercise training or unmanageable
4. Any medical condition that unsuitable for exercise
5. Disagree to trial procedures: exercise, blood draws, questionnaire

What this study is about

In the sponsor’s own words, from the registry.

Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.

Study sites(1)

  • TuCheng Hospital

    New Taipei City, Taiwan

    Recruiting

Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT06851988. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients | Trialion